Du-Var

Acquired By LSL Pharma Group
Skincare and cosmetic manufacturing services in Canada.

About Du-Var

Du-Var is a Consumer company, and was acquired by LSL Pharma Group in July 2025. Skincare and cosmetic manufacturing services in Canada. Du-Var offers products and services including Skincare Products and Private Label Formulations. Its focus areas include Health and Beauty, Manufacturing, Contract Manufacturing and Private Label. Its legal entity is Laboratoire Du-Var.

Company details

Products are created by Du-Var using high-quality ingredients and scientific methods, with operations established since 1947. Contract manufacturing and private label services are offered for cosmetics, natural health products, and animal care items. State-of-the-art facilities ensure adherence to standards like cGMP and NHP, focusing on innovation in formulations while minimizing environmental impact. Research and development processes are supported by stability testing and packaging compatibility, delivering safe and effective products across various textures and applications.

  • Stage Acquired
  • Sectors
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website du-var.com
  • Acquired by LSL Pharma Group (Jul 2025)
  • Legal Name Laboratoire Du-Var
Key Metrics

Products & Services of Du-Var

Du-Var offers a comprehensive portfolio of products and services, including Skincare Products and Private Label Formulations.

Skincare Products
Personal Care

Skincare formulations are developed and manufactured for various uses, ensuring safety and efficacy through scientific backing

Private Label Formulations
Manufacturing Services

Formulations for private labeling are provided, covering items like shampoos and sunscreens that are ready for market distribution

Investors in Du-Var

Du-Var has secured backing from 1 investor. Prominent investors backing the company include LSL Pharma Group.

All
InvestorDescriptionFounded YearDomainLocation
Integrated pharmaceutical products are developed and supplied in Canada.
2023groupelslpharma.comBoucherville, Canada
Premium access

Investor details for Du-Var

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Web traffic of Du-Var

Websites that share an audience with Du-Var (du-var.com).

Similar websites

Websites whose visitors overlap most with Du-Var. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
aimilpharmaceuticals.com
59%
3.7K#2,262,719View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Du-Var

Products are created by Du-Var using high-quality ingredients and scientific methods, with operations established since 1947. Contract manufacturing and private label services are offered for cosmetics, natural health products, and animal care items. State-of-the-art facilities ensure adherence to standards like cGMP and NHP, focusing on innovation in formulations while minimizing environmental impact. Research and development processes are supported by stability testing and packaging compatibility, delivering safe and effective products across various textures and applications.

Du-Var offers Skincare Products and Private Label Formulations.

Du-Var has 1 investor. Key investors include LSL Pharma Group.

Du-Var operates through Laboratoire Du-Var.

Yes. Du-Var was acquired by LSL Pharma Group in July 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available